Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifidobacterium BSL_PS404 Effect on LDL-Cholesterol
NCT04029818Phase 1Completed
- Sponsor
- LGC Biosearch Technologies
- Start
- May 2019
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in hypercholesterolemia (2 arms), sponsored by LGC Biosearch Technologies. Primary endpoint: Low Density Lipoprotein Cholesterol at 8 weeks. Started May 2019; status: completed.
02
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT04029818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04029818.